A digital therapeutic for people with borderline personality disorder in Germany (EPADIP-BPD): a pragmatic, assessor-blind, parallel-group, randomised controlled trial
Authors
Arnoud R. Arntz (ORCID: https://orcid.org/0000-0002-7992-2272)
European Association for Behavioural and Cognitive Therapies
British Association for Behavioural and Cognitive Psychotherapies
Stichting Volksbond Rotterdam
European Commission
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Universiteit Leiden
ZonMw
Universiteit van Amsterdam
Else Kröner-Fresenius-Stiftung
Bundesministerium für Gesundheit
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Universität zu Lübeck
Leids Universitair Medisch Centrum
Université de Bordeaux
Achmea
European College of Neuropsychopharmacology
Servier
International Science Council
Cilag
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
A digital therapeutic for people with borderline personality disorder in Germany (EPADIP-BPD): a pragmatic, assessor-blind, parallel-group, randomised controlled trial
Arnoud R. Arntz, Nele Assmann, Linda T. Betz, Anja Schaich et al.
Citations
12 citations
Journal
The Lancet Psychiatry
Topics
Personality Disorders and Psychopathology
Field-Weighted Citation Impact (FWCI)
27.68
article
A digital therapeutic for people with borderline personality disorder in Germany (EPADIP-BPD): a pragmatic, assessor-blind, parallel-group, randomised controlled trial
Arnoud R. Arntz, Nele Assmann, Linda T. Betz, Anja Schaich, Jan Philipp Klein, Gitta Jacob, Tristan Zindler, Eva Faßbinder, Stefan Borgwardt, Thomas Berger
article en
12 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet PsychiatryVol. 12(5)
Institutions
University of Bern (CH), University of Amsterdam (NL), University of Lübeck (DE)
Funders
National Science Foundation, European Association for Behavioural and Cognitive Therapies, British Association for Behavioural and Cognitive Psychotherapies, Stichting Volksbond Rotterdam, European Commission, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Universiteit Leiden, ZonMw, Universiteit van Amsterdam, Else Kröner-Fresenius-Stiftung, Bundesministerium für Gesundheit, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Universität zu Lübeck, Leids Universitair Medisch Centrum, Université de Bordeaux, Achmea, European College of Neuropsychopharmacology, Servier, International Science Council, Cilag